Bcl2-Independent Chromatin Cleavage is a Very Early Event during Induction of Apoptosis in Mouse Thymocytes after Treatment with Either Dexamethasone or Ionizing Radiation

Radiation Research

Volumn 160, Issue 5, 2003, Pages 559-567

  Hahn, Peter J ^a   Lai, Zhi Wei ^a   Nevaldine, Barbara ^a   Schiff, Ninel ^a   Fiore, Nancy C ^a   Silverstone, Allen E ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; ENDONUCLEASE; PROTEIN BCL 2;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CHROMATIN; CHROMOSOME BREAKAGE; CONTROLLED STUDY; DNA DAMAGE; DNA STRAND BREAKAGE; FEMALE; IONIZING RADIATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; THYMOCYTE; TRANSGENE;

ANIMALS; APOPTOSIS; CELL DIVISION; CELLS, CULTURED; CHROMATIN; DEXAMETHASONE; DNA DAMAGE; FEMALE; GENES, BCL-2; MALE; MICE; MICE, TRANSGENIC; PROTO-ONCOGENE PROTEINS; RADIATION, IONIZING; SIGNAL TRANSDUCTION; THYMUS GLAND; TRANSGENES;

EID: 0348226534     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR3058     Document Type: Article

References (39)

1. C. Scaffidi, S. Fulda, A. Srinivasan, C. Friesen, F. Li, K. J. Tomaselli, K. M. Debatin, P. H. Krammer and M. E. Peter, Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 17, 1675-1687 (1998).
2. C. Scaffidi, I. Schmitz, J. Zha, S. J. Korsmeyer, P. H. Krammer and M. E. Peter, Differential modulation of apoptosis sensitivity in CD95 type I and type II cells. J. Biol. Chem. 274, 22532-22538 (1999).
3. I. Schmitz, H. Walczak, P. H. Krammer and M. E. Peter, Differences between CD95 type I and II cells detected with the CD95 ligand. Cell Death Differ. 6, 821-822 (1999).
4. M. Enari, H. Sakahira, H. Yokoyama, K. Okawa, A. Iwamatsu and S. Nagata, A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391, 43-50 (1998); Erratum, Nature 393, 396 (1998).
5. M. Enari, H. Sakahira, H. Yokoyama, K. Okawa, A. Iwamatsu and S. Nagata, A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391, 43-50 (1998); Erratum, Nature 393, 396 (1998).
6. H. Sakahira, M. Enari and S. Nagata, Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 391, 96-99 (1998).
7. R. Hakem, A. Hakem, G. S. Duncan, J. T. Henderson, M. Woo, M. S. Soengas, A. Elia, J. L. de la Pompa, D. Kagi and T. W. Mak, Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell 94, 339-352 (1998).
8. R. T. Allen, M. W. Cluck and D. K. Agrawal, Mechanisms controlling cellular suicide: Role of Bcl-2 and caspases. Cell. Mol. Life Sci. 54, 427-445 (1998).
9. D. R. Green and J. C. Reed, Mitochondria and apoptosis. Science 281, 1309-1312 (1998).
10. R. M. Kluck, E. Bossy-Wetzel, D. R. Green and D. D. Newmeyer, The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis. Science 275, 1132-1136 (1997).
11. E. Bossy-Wetzel, D. D. Newmeyer and D. R. Green, Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization. EMBO J. 17, 37-49 (1998).
12. B. Endlich, I. R. Radford, H. B. Forrester and W. C. Dewey, Computerized video time-lapse microscopy studies of ionizing radiation-induced rapid-interphase and mitosis-related apoptosis in lymphoid cells. Radiat. Res. 153, 36-48 (2000).
13. D. Green and G. Kroemer, The central executioners of apoptosis: caspases or mitochondria? Trends Cell Biol. 8, 267-271 (1998).
14. T. Hirsch, B. Dallaporta, N. Zamzami, S. A. Susin, L. Ravagnan, I. Marzo, C. Brenner and G. Kroemer, Proteasome activation occurs at an early, premitochondrial step of thymocyte apoptosis. J. Immunol. 161, 35-40 (1998).
15. N. Mailand, J. Falck, C. Lukas, R. G. Syljuasen, M. Welcker, J. Bartek and J. Lukas, Rapid destruction of human Cdc25A in response to DNA damage. Science 288, 1425-1429 (2000).
16. N. Mori, J. Yamate, A. P. Stassen, S. Oka, M. Okumoto, A. Tsubura, T. Akamatsu, S. Sakuma and P. Demant, Modulations of glucocorticoid-induced apoptosis linked to the p53 deletion and to the apoptosis susceptibility gene Rapop1 (Radiation-induced apoptosis 1). Oncogene 18, 4282-4285 (1999).
17. P. Benveniste and A. Cohen, P53 expression is required for thymocyte apoptosis induced by adenosine deaminase deficiency. Proc. Natl. Acad. Sci. USA 92, 8373-8377 (1995).
18. R. Agami, G. Blandino, M. Oren and Y. Shaul, Interaction of c-Abl and p73α and their collaboration to induce apoptosis. Nature 399, 809-813 (1999).
19. L. A. Pena, Z. Fuks and R. Kolesnick, Stress-induced apoptosis and the sphingomyelin pathway. Biochem. Pharmacol. 53, 615-621 (1997).
20. J. G. Reyes, I. G. Robayna, P. S. Delgado, I. H. Gonzalez, J. Q. Aguiar, F. E. Rosas, L. F. Fanjul and C. M. R. Galarreta, c-Jun is a downstream target for ceramide-activated protein phosphatase in A431 cells. J. Biol. Chem. 271, 21375-21380 (1996).
21. L. Testolin, C. Carson, Y. Wang, P. R. Walker, U. Armato and M. Sikorska, Jun and JNK kinase are activated in thymocytes in response to VM26 and radiation but not glucocorticoids. Exp. Cell Res. 230, 220-232 (1997).
22. P. Zhang, B. S. Miller, S. A. Rosenzweig and N. R. Bhat, Activation of C-jun N-terminal kinase/stress-activated protein kinase in primary glial cultures. J. Neurosci. Res. 46, 114-121 (1996).
23. + thymocytes. J. Exp. Med. 188, 1817-1830 (1998).
24. J. R. Matthews and R. T. Hay, Regulation of the DNA binding activity of NF-κB. Int. J. Biochem. Cell Biol. 27, 865-879 (1995).
25. J. Delic, P. Masdehors, S. Omura, J. M. Cosset, J. Dumont, J. L. Binet and H. Magdelenat, The proteasome inhibitor lactacystin induces apoptosis and sensitizes chemo- and radioresistant human chronic lymphocytic leukaemia lymphocytes to TNF-α-initiated apoptosis. Br. J. Cancer 77, 1103-1107 (1998).
26. J. G. Boesen-de Cock, A. D. Tepper, E. de Vries, W. J. van Blitterswijk and J. Borst, Common regulation of apoptosis signaling induced by CD95 and the DNA-damaging stimuli etoposide and gamma-radiation downstream from caspase-8 activation. J. Biol. Chem. 274, 14255-14261 (1999).
27. T. K. Li, A. Y. Chen, C. Yu, Y. Mao, H. Wang and L. F. Liu, Activation of topoisomerase II-mediated excision of chromosomal DNA loops during oxidative stress. Genes Dev. 13, 1553-1560 (1999).
28. Z. W. Lai, N. C. Fiore, P. J. Hahn, T. A. Gasiewicz and A. E. Silverstone, Differential effects of diethylstilbestrol and 2,3,7,8-tetrachlorodibenzo-p-dioxin on thymocyte differentiation, proliferation, and apoptosis in bcl-2 transgenic mouse fetal thymus organ culture. Toxicol. Appl. Pharmacol. 168, 15-24 (2000).
29. J. E. Staples, N. C. Fiore, D. E. Frazier, Jr., T. A. Gasiewicz and A. E. Silverstone, Overexpression of the anti-apoptotic oncogene, bcl-2, in the thymus does not prevent thymic atrophy induced by estradiol or 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Appl. Pharmacol. 151, 200-210 (1998).
30. J. A. Longo, B. Nevaldine, S. L. Longo, J. A. Winfield and P. J. Hahn, An assay for quantifying DNA double-strand break repair that is suitable for small numbers of unlabeled cells. Radiat. Res. 147, 35-40 (1997).
31. J. Gratiot-Deans, R. Merino, G. Nunez and L. A. Turka, Bcl-2 expression during T-cell development: Early loss and late return occur at specific stages of commitment to differentiation and survival. Proc. Natl. Acad. Sci. USA 91, 10685-10689 (1994).
32. J. Gratiot-Deans, L. Ding, L. A. Turka and G. Nunez, bcl-2 protooncogene expression during human T cell development. Evidence for biphasic regulation. J. Immunol. 151, 83-91 (1993).
33. N. C. Moore, G. Anderson, G. T. Williams, J. J. Owen and E. J. Jenkinson, Developmental regulation of bcl-2 expression in the thymus. Immunology 81, 115-119 (1994).
34. C. L. Sentman, J. R. Shutter, D. Hockenbery, O. Kanagawa and S. J. Korsmeyer, bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 67, 879-888 (1991).
35. F. J. Geske, A. C. Nelson, R. Lieberman, R. Strange, T. Sun and L. E. Gerschenson, DNA repair is activated in early stages of p53-induced apoptosis. Cell Death Differ. 7, 393-401 (2000).
36. J. Zhang, X. Wang, K. E. Bove and M. Xu, DNA fragmentation factor 45-deficient cells are more resistant to apoptosis and exhibit different dying morphology than wild-type control cells. J. Biol. Chem. 274, 37450-37454 (1999).
37. G. Gil-Gomez, A. Berns and H. J. Brady, A link between cell cycle and cell death: Bax and Bcl-2 modulate Cdk2 activation during thymocyte apoptosis. EMBO J. 17, 7209-7218 (1998).
38. J. G. Pastorino, S. T. Chen, M. Tafani, J. W. Snyder and J. L. Farber, The overexpression of Bax produces cell death upon induction of the mitochondrial permeability transition. J. Biol. Chem. 273, 7770-7775 (1998).
39. J. M. Jurgensmeier, Z. Xie, Q. Deveraux, L. Ellerby, D. Bredesen and J. C. Reed, Bax directly induces release of cytochrome c from isolated mitochondria. Proc. Natl. Acad. Sci. USA 95, 4997-5002 (1998).